Bioventus (BVS) Long-Term Investments (2020 - 2026)

Bioventus' Long-Term Investments history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• Quarterly Long-Term Investments rose 19.7% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 19.7% YoY) and the FY2025 annual result came in at $2.3 million, up 21.19% from the prior year.
• Long-Term Investments was $2.1 million for Q1 2026 at Bioventus, down from $2.3 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $78.5 million in Q3 2022 and bottomed at $1.7 million in Q2 2025.
• A 5-year average of $9.5 million and a median of $2.6 million in 2023 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments jumped 302.84% — and 2023, when it tumbled 91.67%.
• Bioventus' Long-Term Investments stood at $2.6 million in 2022, then gained by 19.84% to $3.1 million in 2023, then slumped by 39.76% to $1.9 million in 2024, then increased by 21.19% to $2.3 million in 2025, then declined by 8.33% to $2.1 million in 2026.
• Business Quant data shows BVS's Long-Term Investments at $2.1 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.